Finasteride Market Report 2025 (Global Edition)

Global Finasteride Market Report 2025 Market Size Split by Application (Benign Prostatic Hyperplasia (BPH) , Male pattern baldness ), by Type (Branded , Generic ), by Distribution Channel (Hospi...

Finasteride Market Report Description

We have various report editions of Finasteride Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Competitive Landscape of the Finasteride Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

Top Companies Market Share in Finasteride Industry: (In no particular order of Rank)

• Guangdong Eashu Pharmacetical
• Shandong Renhetang Pharmaceutical
• Henan Topfond
• RelonChem
• Actavis
• Cipla
• Sandoz
• Teva Pharmaceuticals
• Zhejiang CONBA Pharmaceutical
• Merck
• Dr. Reddy
• Accord Pharmaceuticals
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Finasteride

Which Region Dominates the Finasteride Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The market for finasteride is expanding in North America due to factors such as the increased prevalence of benign prostatic hyperplasia and male pattern baldness, rising awareness of potential therapies, and an increasing focus on men's health. To take advantage of this trend, pharmaceutical companies are increasing their presence in the area, propelling additional market expansion and innovation in finasteride-based products.

Which Region is Expanding at the Fastest CAGR?

The Europe region is witnessing an increase in the sales of reagents. The market for finasteride is expanding in Europe due to a rise in benign prostatic hyperplasia and male pattern baldness. Growth in the market is being driven by rising knowledge of prostate health and hair loss treatments and improvements in the healthcare infrastructure. To address the rising demand, pharmaceutical companies are taking advantage of these chances by launching new finasteride formulations and increasing their market share in Europe.

The current report Scope analyzes Finasteride Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Finasteride Market Analysis

According to Cognitive Market Research, the global Finasteride market size was estimated at USD 125.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 50.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.2% from 2024 to 2031. Male pattern baldness and benign prostatic hyperplasia are becoming more common, and people are becoming more aware of the treatments that may be used to treat them. These factors are driving growth in the finasteride market in North America. The internet distribution channel is a rapidly expanding area that provides consumers seeking finasteride for hair loss and prostate health concerns with accessibility and ease. As demographic trends and technology improvements intersect, North America continues to be a major force behind market expansion. In summary, pharmaceutical businesses have considerable potential to profit from the expanding demand for finasteride products due to the dynamic landscape of the region.

Country Analysis

• According to Cognitive Market Research, the US had a major share in the Finasteride market with a market size of USD 39.51 million in 2024 and is projected to grow at a CAGR of 1.0% during the forecast period. The demand is amplified by the nation's with a significant portion of the population entering older age brackets, there's a higher prevalence of conditions like male pattern baldness and benign prostatic hyperplasia, driving demand for finasteride. 
• The Canada Finasteride market had a market share of USD 6.01 million in 2024 and is projected to grow at a CAGR of 2.0% during the forecast period. Canada's rising advanced healthcare facilities, facilitating greater access to finasteride treatments and increasing awareness of available options.
• The Mexico Finasteride market is projected to witness growth at a CAGR of 6.9% during the forecast period with a market size of USD 532.21 million in 2024.

Europe Finasteride Market Analysis

According to Cognitive Market Research, with a market value of USD 125.2 million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 1.5% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 37.56 million. The demand for efficient therapies is being driven by the rising incidence of benign prostatic hyperplasia and male pattern baldness, which is fueling the finasteride market in Europe. Notably, the generic pharmaceutical industry is growing at a significant rate and provides affordable substitutes for name-brand drugs. Europe is a promising region for market expansion as knowledge of men's health increases and healthcare systems place more emphasis on it. In summary, the region's adoption of generic finasteride choices highlights its dedication to offering easily accessible and reasonably priced healthcare treatments, hence driving additional market expansion.

• The United Kingdom Finasteride market had a market share of USD 6.31 million in 2024 and is projected to grow at a CAGR of 2.3% during the forecast period. In the UK, Finasteride sales witness an upswing due to the aggressive marketing campaigns by pharmaceutical companies directly target consumers, promoting awareness. 
• The France Finasteride market is projected to witness growth at a CAGR of 0.7% during the forecast period with a market size of USD 3.46 million in 2024.
• According to Cognitive Market Research, the Germany Finasteride market size was valued at USD 7.44 million in 2024 and is projected to grow at a CAGR of 1.7% during the forecast period. In Germany, Finasteride sales surge due to the driving demand for finasteride products. 
• The Italy Finasteride market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 377.23 million in 2024.
• The Russia Finasteride market is projected to witness growth at a CAGR of 0.5% during the forecast period with a market size of USD 5.82 million in 2024.
• The Spain Finasteride market is projected to witness growth at a CAGR of 0.6% during the forecast period with a market size of USD 3.08 million in 2024.
• The Luxembourg Finasteride market is projected to witness growth at a CAGR of 1.6% during the forecast period with a market size of USD 1.16 million in 2024.
• The Portugal Finasteride market is projected to witness growth at a CAGR of 1.3% during the forecast period with a market size of USD 0.79 million in 2024.
• The Greece Finasteride market is projected to witness growth at a CAGR of 1.8% during the forecast period with a market size of USD 0.45 million in 2024.
• Rest of Europe Finasteride market is projected to witness growth at a CAGR of 0.2% during the forecast period with a market size of USD 5.82 million in 2024.

 

Asia Pacific Finasteride Market Analysis

According to Cognitive Market Research, the global Finasteride market size was estimated at USD 125.2 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 28.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031. The finasteride market in Asia Pacific is expanding significantly against the backdrop of rising awareness of benign prostatic hyperplasia and male pattern baldness. This expansion is being driven by the growing e-commerce platform, which makes finasteride easily accessible to customers around the region. Asia Pacific has enormous market growth potential due to its vast population and rising disposable incomes. To sum up, the adoption of online channels by the region is indicative of a changing healthcare environment in which accessibility and convenience are critical factors in fulfilling the increasing demand for finasteride products.

• According to Cognitive Market Research, the China Finasteride market size was valued at USD 12.96 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Finasteride sales surge in China due to the nation's rising incomes enable more individuals to afford healthcare treatments, including finasteride for conditions like male pattern baldness.
• The Japan Finasteride market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 3.97 million in 2024.
• The India Finasteride market had a market share of USD 3.46 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The demand is augmented by India's increasing urban areas often have higher concentrations of healthcare facilities, leading to greater accessibility to finasteride treatments.
• The South Korea Finasteride market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD 2.88 million in 2024.
• The Australia Finasteride market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD 1.50 million in 2024.
• The South East Asia Finasteride market is projected to witness growth at a CAGR of 6.0% during the forecast period with a market size of USD 1.99 million in 2024.
• The Rest of Asia Pacific Finasteride market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 2.04 million in 2024.

South America Finasteride Market Analysis

According to Cognitive Market Research, the global Finasteride market size was estimated at USD 125.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 6.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.4% from 2024 to 2031. The market for finasteride is expanding in Latin America as people become more aware of benign prostatic hyperplasia and male pattern baldness. The rise in demand for branded finasteride medications, which is mostly due to customer confidence in well-known pharmaceutical names, is particularly significant. Latin America has a growing middle class and a developing healthcare system, which means there are many prospects for market growth. To sum up, the region's inclination toward branded drugs emphasizes the value of reputation and dependability when selecting pharmaceuticals, which is fueling the finasteride market's consistent expansion throughout Latin America.

• According to Cognitive Market Research, the Brazil Finasteride market size was valued at USD 2.68 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. Finasteride sales flourish in Brazil due to the nation's thriving pharmaceutical industry and increasing investments in healthcare infrastructure.
• The Argentina Finasteride market had a market share of USD 1.05 million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. The demand is augmented by Argentina's commitment to increasing education and awareness about male pattern baldness and benign prostatic hyperplasia.
• The Colombia Finasteride market is projected to witness growth at a CAGR of 2.2% during the forecast period with a market size of USD 0.56 million in 2024.
• The Peru Finasteride market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD 0.51 million in 2024.
• The Chile Finasteride market is projected to witness growth at a CAGR of 2.7% during the forecast period with a market size of USD 0.45 million in 2024.
• The Rest of Latin America Finasteride market is projected to witness growth at a CAGR of 1.5% during the forecast period with a market size of USD 1.01 million in 2024.

Middle East Finasteride Market Analysis

According to Cognitive Market Research, the global Finasteride market size was estimated at USD 125.2 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 2.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. The market for finasteride is expanding gradually across the Middle East and Africa as people become more aware of benign prostatic hyperplasia and male pattern baldness. Notably, the pharmaceutical retail business is experiencing notable expansion, with a demand for both branded and generic finasteride products. The area offers great prospects for market expansion due to its expanding healthcare expenditures and growing healthcare infrastructure. To sum up, the availability of finasteride in retail settings highlights the significance of easy access to medical care, which is fueling the market's steady expansion across the Middle East and Africa.

• According to Cognitive Market Research, the GCC Countries Finasteride market size was valued at USD 1.07 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Finasteride sales flourish in the GCC Countries due to the leading to a higher incidence of conditions like male pattern baldness and benign prostatic hyperplasia.
• The Egypt Finasteride market is projected to witness growth at a CAGR of 3.0% during the forecast period with a market size of USD 0.26 million in 2024.
• The South Africa Finasteride market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 0.40 million in 2024. Finasteride sales flourish in the South Africa due to the well-established healthcare system ensures widespread access to finasteride treatments, contributing to market growth.
• The Turkey Finasteride market is projected to witness growth at a CAGR of 2.2% during the forecast period with a market size of USD 0.22 million in 2024.
• The Nigeria Finasteride market is projected to witness growth at a CAGR of 1.8% during the forecast period with a market size of USD 0.26 million in 2024.
• The Rest of MEA Finasteride market is projected to witness growth at a CAGR of 1.7% during the forecast period with a market size of USD 0.30 million in 2024.

Finasteride Market Analysis

Finasteride Application Segment Analysis

According to Cognitive Market Research, Benign Prostatic Hyperplasia (BPH) held the major market share over the forecast period. Due to the rising incidence of benign prostatic hyperplasia, the finasteride market is growing (BPH). Aging populations and growing awareness of BPH symptoms are driving up demand for drugs like finasteride. Pharmaceutical firms are investing in the research and promotion of finasteride-based therapies as men look for ways to manage the urine symptoms associated with BPH, which is fueling the market's continued rise.

Male pattern baldness is the fastest-growing category over the forecast period. The market for finasteride is expanding due to male pattern baldness. Men are losing hair faster than ever, driving up demand for hair loss medications like finasteride. Increased treatment choices and awareness-raising initiatives have further spurred market growth. Pharmaceutical companies are introducing innovative finasteride formulations to capitalize on this trend and meet the increasing demands of people looking for remedies for male pattern baldness.

• Benign Prostatic Hyperplasia (BPH) 
• Male pattern baldness 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Finasteride Industry. Request a Free Sample PDF!

Finasteride Type Segment Analysis

According to Cognitive Market Research, Branded finasteride medications hold a prominent market share. The market is expanding because of its well-established reputation and perceived effectiveness. Many customers choose branded products over generic ones, even if generic alternatives are readily available because they believe that well-known pharmaceutical names are more trustworthy and reliable. Branded manufacturers maintain their growth trajectory by maintaining their dominance in the finasteride market through aggressive marketing efforts and effective pricing methods.

Generic is the fastest-growing category over the forecast period. The market for generic finasteride is growing as more people choose less expensive substitutes for name-brand drugs. Due to its comparable effectiveness and reduced cost, people seeking therapy for illnesses such as benign prostatic hyperplasia and male pattern baldness are finding generic finasteride to be increasingly appealing. The rising trend of generic drugs is driven by efforts to limit healthcare costs and growing acceptance and trust in these drugs.

• Branded 
• Generic 

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Finasteride Distribution Channel Segment Analysis

According to Cognitive Market Research, Hospital Pharmacies held the major market share over the forecast period. By giving patients receiving treatment for ailments like benign prostatic hyperplasia and male pattern baldness easy access to the drug, hospital pharmacies are helping the finasteride industry expand. Hospital pharmacies are stocking and distributing finasteride due to healthcare facilities' growing recognition of the significance of managing men's health. This facilitates the drug's wider availability and helps the market grow.

Online Providers are the fastest-growing category over the forecast period. Online pharmacies that provide easy access to finasteride for people seeking treatment for benign prostatic hyperplasia and male pattern baldness are having a substantial impact on the market's growth. Online providers are expediting finasteride prescriptions, expanding the medication's reach, and driving market growth through enhanced accessibility. This is due to the rise of telemedicine and direct-to-consumer healthcare platforms.

• Hospital Pharmacies 
• Online Providers 
• Drug Stores and Retail Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion